Hematopoietic Stem Cell TransplantationBone Marrow TransplantationHematopoietic Stem CellsTransplantation, HomologousGraft vs Host DiseaseUnrelated DonorsTransplantation ConditioningHistocompatibility TestingStem Cell TransplantationTransplantation, AutologousBone MarrowStem CellsBone Marrow CellsHematologic NeoplasmsTissue DonorsTransplantation ChimeraHematopoiesisWhole-Body IrradiationPeripheral Blood Stem Cell TransplantationGraft SurvivalLeukemiaBusulfanHistocompatibilityHematopoietic Stem Cell MobilizationTreatment OutcomeAntigens, CD34Liver TransplantationCell DifferentiationCord Blood Stem Cell TransplantationAnemia, AplasticMice, Inbred C57BLRecurrenceCell LineageColony-Forming Units AssayRetrospective StudiesChimerismCombined Modality TherapyGraft vs Leukemia EffectLeukemia, Myeloid, AcuteTime FactorsImmunosuppressive AgentsTransplantation, IsogeneicStem Cell NicheRemission InductionMyeloablative AgonistsFlow CytometryHepatic Veno-Occlusive DiseaseCyclophosphamideHematologic DiseasesEmbryonic Stem CellsKidney TransplantationAdult Stem CellsMesenchymal Stem Cell TransplantationHLA AntigensMyelodysplastic SyndromesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBone and BonesTransplantation ImmunologySevere Combined ImmunodeficiencyPrecursor Cell Lymphoblastic Leukemia-LymphomaCells, CulturedSurvival AnalysisMultiple MyelomaCell TransplantationFetal BloodGranulocyte Colony-Stimulating FactorSurvival RateGraft vs Tumor EffectBone Marrow PurgingCell SeparationRadiation ChimeraLymphocyte TransfusionGraft RejectionT-LymphocytesDisease-Free SurvivalLymphocyte DepletionAcute DiseaseMelphalanStem Cell FactorSiblingsLeukemia, MyeloidImmunosuppressionCytomegalovirus InfectionsCell ProliferationLymphoma, Non-HodgkinMultipotent Stem CellsMesenchymal Stromal CellsBone Marrow DiseasesVidarabinePluripotent Stem CellsAntineoplastic Combined Chemotherapy ProtocolsFollow-Up StudiesHeart TransplantationLiving DonorsAntilymphocyte SerumMice, SCIDSalvage TherapyOrgan TransplantationHematopoietic SystemAntigens, CD